Filter zurücksetzen
Stichworte
Leukämie ×
Zeige mehr Stichworte
Inhaltsverzeichnis
  1. 1. Klinische Studie
  2. 2. Routinedokumentation
  3. 3. Register-/Kohortenstudien
  4. 4. Qualitätssicherung
  5. 5. Datenstandard
  6. 6. Patientenfragebogen
  7. 7. Medizinische Fachrichtung
Ausgewählte Datenmodelle

Sie müssen eingeloggt sein, um mehrere Datenmodelle auszuwählen und diese herunterzuladen oder zu analysieren.

380 Suchergebnisse.
Relevanz Bewertung Neue zuerst Alte zuerst

Leukemia NCT00085124 Follow-Up - CALGB: 10201 Notification of death - 2076956v3.0 - CALGB: 10201 Notification of death

- 09.01.15 - 1 Formular, 1 Itemgruppe, 16 Datenelemente, 1 Sprache
Itemgruppe: CCRR MODULE
CALGB: 10201 Notification of death Daunorubicin and Cytarabine With or Without Oblimersen in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=B22B0174-18C2-5157-E034-0003BA12F5E7

Leukemia NCT00898079 Follow-Up - Off Protocol Therapy Follow-up (OPTF) Report [ABTR01B1] - 2172125v3.0 - Off Protocol Therapy Follow-up (OPTF) Report [ABTR01B1]

- 09.01.15 - 1 Formular, 4 Itemgruppen, 23 Datenelemente, 1 Sprache
Itemgruppen: Header, Patient Status Information, Events of Interest., CCRR MODULE
Off Protocol Therapy Follow-up (OPTF) Report [ABTR01B1] Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=C0DB9E9B-20A9-68CC-E034-0003BA12F5E7

Leukemia NCT00085124 Follow-Up - CALGB: 10201 FOLLOW-UP FORM - 2031846v3.0 - CALGB: 10201 FOLLOW-UP FORM

- 09.01.15 - 1 Formular, 7 Itemgruppen, 39 Datenelemente, 1 Sprache
Itemgruppen: CALGB Form, VITAL STATUS, DISEASE FOLLOW-UP STATUS, NOTICE OF PROGRESSION, RECOVERY, TRANSPLANT TREATMENT PLAN, CCRR MODULE
CALGB: 10201 FOLLOW-UP FORM Daunorubicin and Cytarabine With or Without Oblimersen in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=AD85E4FA-DE35-3551-E034-0003BA12F5E7

Leukemia NCT00085124 Lab - CALGB: 10201 PERIPHERAL BLOOD AND BONE MARROW REPORT FORM - 2031273v3.0 - CALGB: 10201 PERIPHERAL BLOOD AND BONE MARROW REPORT FORM

- 09.01.15 - 1 Formular, 6 Itemgruppen, 43 Datenelemente, 1 Sprache
Itemgruppen: CALGB Form, BONE MARROW, BONE MARROW DIFFERENTIAL, PERIPHERAL BLOOD DIFFERENTIAL, Degree of Dyspoiesis Present, CCRR MODULE
CALGB: 10201 PERIPHERAL BLOOD AND BONE MARROW REPORT FORM Daunorubicin and Cytarabine With or Without Oblimersen in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=AD85FF2B-39F3-35D3-E034-0003BA12F5E7

Leukemia NCT00085124 Toxicity - CALGB: 10201 ADVERSE EVENT FORM - 2070578v3.0 - CALGB: 10201 ADVERSE EVENT FORM

- 09.01.15 - 1 Formular, 3 Itemgruppen, 25 Datenelemente, 1 Sprache
Itemgruppen: CALGB Form, EXPECTED ADVERSE EVENTS, CCRR MODULE
CALGB: 10201 ADVERSE EVENT FORM Daunorubicin and Cytarabine With or Without Oblimersen in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=AD846683-4685-2F05-E034-0003BA12F5E7

NCT00049517 Follow-Up - E1900 Cover Page for Acute Leukemia Disease Assessment Form - 2075100v3.0 - E1900 Cover Page for Acute Leukemia Disease Assessment Form

- 09.01.15 - 1 Formular, 4 Itemgruppen, 12 Datenelemente, 1 Sprache
Itemgruppen: Header, On Treatment, Off Treatment, CCRR MODULE
E1900 Cover Page for Acute Leukemia Disease Assessment Form Combination Chemotherapy With or Without Monoclonal Antibody Therapy Followed by Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=B19AB05D-F815-25DE-E034-0003BA12F5E7

Leukemia NCT01041703 Eligibility - E2906 Registration Worksheet (step 3) - 3083677v1.0 - E2906 Registration Worksheet (step 3)

- 09.01.15 - 1 Formular, 1 Itemgruppe, 5 Datenelemente, 1 Sprache
Itemgruppe: Eligibility
E2906 Registration Worksheet (step 3) Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=860606B1-A35A-DE3F-E040-BB89AD4345DE

Leukemia NCT00074282 Eligibility - E2903 Registration Worksheet (step 2) - 2787779v1.0 - E2903 Registration Worksheet (step 2)

- 09.01.15 - 1 Formular, 1 Itemgruppe, 3 Datenelemente, 1 Sprache
Itemgruppe: Eligibility
E2903 Registration Worksheet (step 2) Pentostatin, Cyclophosphamide, and Rituximab Followed By Alemtuzumab in Treating Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=57BCF96C-D19C-414F-E044-0003BA3F9857

Leukemia NCT00792948 Registration - Southwest Oncology Group S0805 Registration Worksheet Form (Step 1) - 3135175v1.0 - Southwest Oncology Group S0805 Registration Worksheet Form (Step 1)

- 09.01.15 - 1 Formular, 8 Itemgruppen, 20 Datenelemente, 1 Sprache
Itemgruppen: Protocol Information, SWOG PATIENT ID, DEMOGRAPHY, For SWOG Institutions:, Patient Information, Stratification Question, Indicate how the patient answered the following questions on the consent form, Patient Eligibility
Southwest Oncology Group S0805 Registration Worksheet Form (Step 1) Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=8FB90D5C-D5F7-9108-E040-BB89AD43238E

Leukemia NCT00074282 Eligibility - E2903 Registration Worksheet (step 1) - 2787672v1.0 - E2903 Registration Worksheet (step 1)

- 09.01.15 - 1 Formular, 1 Itemgruppe, 13 Datenelemente, 1 Sprache
Itemgruppe: Eligibility
E2903 Registration Worksheet (step 1) Pentostatin, Cyclophosphamide, and Rituximab Followed By Alemtuzumab in Treating Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=57BCD093-C3A2-3B7C-E044-0003BA3F9857

Leukemia NCT01013961 Eligibility - E1908 Registration Worksheet (step 1) - 2988263v1.0 - E1908 Registration Worksheet (step 1)

- 09.01.15 - 1 Formular, 1 Itemgruppe, 3 Datenelemente, 1 Sprache
Itemgruppe: Eligibility
E1908 Registration Worksheet (step 1) Rituximab and Alemtuzumab in Treating Older Patients With Progressive Chronic Lymphocytic Leukemia Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=7D742C85-295F-A7C8-E040-BB89AD432037

Leukemia NCT01041703 Eligibility - E2906 Registration Worksheet (step 1) - 3082845v1.0 - E2906 Registration Worksheet (step 1)

- 09.01.15 - 1 Formular, 1 Itemgruppe, 16 Datenelemente, 1 Sprache
Itemgruppe: Eligibility
E2906 Registration Worksheet (step 1) Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=85FA2555-1EC1-F884-E040-BB89AD432656

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video